Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Chondroitin Sulfate is an oral combination pharmaceutical product developed and manufactured by Hangzhou Guoguang Pharmaceutical. It is primarily composed of chondroitin sulfate, a glycosaminoglycan that is a vital structural component of cartilage, alongside a complex of vitamins including Vitamin B1 (thiamine), Vitamin B2 (riboflavin), Vitamin B6 (pyridoxine), and Vitamin C (ascorbic acid). Chondroitin sulfate works by supporting the extracellular matrix of cartilage and inhibiting degradative enzymes such as matrix metalloproteinases, which helps maintain joint integrity and reduce inflammation. The addition of B-vitamins is intended to support neuronal metabolism and nerve repair, while Vitamin C provides antioxidant protection and aids in collagen synthesis. This combination is specifically indicated for the treatment of orthopedic and neurological conditions, including arthralgia (joint pain), neuralgia, migraines, and tinnitus associated with streptomycin use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on compound chondroitin sulfate.